BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 1443562)

  • 1. Noncolorimetric measurement of cell activity in three-dimensional histoculture using the tetrazolium dye 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide: the pixel image analysis of formazan crystals.
    Colangelo D; Guo HY; Connors KM; Silvestro L; Hoffman RM
    Anal Biochem; 1992 Aug; 205(1):8-13. PubMed ID: 1443562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of the pH dependence of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide-formazan absorption on chemosensitivity determined by a novel tetrazolium-based assay.
    Plumb JA; Milroy R; Kaye SB
    Cancer Res; 1989 Aug; 49(16):4435-40. PubMed ID: 2743332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of drug response in human tumors histocultured in vitro with an image-analysis MTT end point and in vivo xenografted in nude mice.
    Colangelo D; Guo HY; Connors KM; Kubota T; Silvestro L; Hoffman RM
    Anticancer Res; 1992; 12(5):1373-6. PubMed ID: 1444193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The MTT assay for chemosensitivity testing of human tumors of the central nervous system. Part I: Evaluation of test-specific variables.
    Nikkhah G; Tonn JC; Hoffmann O; Kraemer HP; Darling JL; Schönmayr R; Schachenmayr W
    J Neurooncol; 1992 May; 13(1):1-11. PubMed ID: 1613535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tetrazolium-based assays for cellular viability: a critical examination of selected parameters affecting formazan production.
    Vistica DT; Skehan P; Scudiero D; Monks A; Pittman A; Boyd MR
    Cancer Res; 1991 May; 51(10):2515-20. PubMed ID: 2021931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ammonia-containing dimethyl sulfoxide: an improved solvent for the dissolution of formazan crystals in the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assay.
    Wang H; Wang F; Tao X; Cheng H
    Anal Biochem; 2012 Feb; 421(1):324-6. PubMed ID: 22100715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Backscattered light confocal imaging of intracellular MTT-formazan crystals.
    Bernas T; Dobrucki JW
    Microsc Res Tech; 2004 Jun; 64(2):126-34. PubMed ID: 15352083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of an aqueous soluble tetrazolium/formazan assay for cell growth assays in culture.
    Cory AH; Owen TC; Barltrop JA; Cory JG
    Cancer Commun; 1991 Jul; 3(7):207-12. PubMed ID: 1867954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytotoxic amyloid peptides inhibit cellular 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction by enhancing MTT formazan exocytosis.
    Liu Y; Schubert D
    J Neurochem; 1997 Dec; 69(6):2285-93. PubMed ID: 9375659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screen anticancer drug in vitro using resonance light scattering technique.
    Chen Z; Liu G; Chen M; Xu B; Peng Y; Chen M; Wu M
    Talanta; 2009 Feb; 77(4):1365-9. PubMed ID: 19084650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adaptation of the rapid automated tetrazolium dye based (MTT) assay for chemosensitivity testing in childhood leukemia.
    Pieters R; Huismans DR; Leyva A; Veerman AJ
    Cancer Lett; 1988 Aug; 41(3):323-32. PubMed ID: 3165705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Both oxidative stress-dependent and independent effects of amyloid beta protein are detected by 3-(4,5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) reduction assay.
    Abe K; Saito H
    Brain Res; 1999 May; 830(1):146-54. PubMed ID: 10350568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current methodology of MTT assay in bacteria - A review.
    Grela E; Kozłowska J; Grabowiecka A
    Acta Histochem; 2018 May; 120(4):303-311. PubMed ID: 29606555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of plasma membrane in bioreduction of two tetrazolium salts, MTT, and CTC.
    Bernas T; Dobrucki JW
    Arch Biochem Biophys; 2000 Aug; 380(1):108-16. PubMed ID: 10900139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A study of some variables in a tetrazolium dye (MTT) based assay for cell growth and chemosensitivity.
    Twentyman PR; Luscombe M
    Br J Cancer; 1987 Sep; 56(3):279-85. PubMed ID: 3663476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modification of the MTT method for the study of bilirubin cytotoxicity.
    Ngai KC; Yeung CY; Karlberg J
    Acta Paediatr Jpn; 1998 Aug; 40(4):313-7. PubMed ID: 9745771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of a rapid tetrazolium-based colorimetric assay for selecting anticancer drugs.
    Chen CF; Hwang JM; Wu CH; Chen CS; Chen KY
    Zhonghua Yi Xue Za Zhi (Taipei); 1990 Jul; 46(1):7-16. PubMed ID: 2176928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitamin A as an enzyme that catalyzes the reduction of MTT to formazan by vitamin C.
    Chakrabarti R; Kundu S; Kumar S; Chakrabarti R
    J Cell Biochem; 2000 Sep; 80(1):133-8. PubMed ID: 11029760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-sensitivity antitumor drug sensitivity testing.
    Kondo T; Wada K; Kawashima M; Sato Y; Yamauchi M
    Oncology; 1994; 51(6):535-9. PubMed ID: 7970499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measurement of cellular 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction activity and lactate dehydrogenase release using MTT.
    Abe K; Matsuki N
    Neurosci Res; 2000 Dec; 38(4):325-9. PubMed ID: 11164558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.